Skip to main content

Radiotherapy

  • Chapter
Renal Cell Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Motzer RJ, Bander NH, Nanus DM: Renal-cell carcinoma [see comment]. N Engl J Med 335:865–875, 1996.

    Article  PubMed  CAS  Google Scholar 

  2. Figlin RA: Renal cell carcinoma: management of advanced disease. J Urol 161:381–166, 1999; discussion 386–387.

    Article  PubMed  CAS  Google Scholar 

  3. Zekri J, Ahmed N, Coleman RE, et al.: The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 19:379–382, 2001.

    PubMed  CAS  Google Scholar 

  4. Motzer RJ, Mazumdar M, Bacik J, et al.: Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530–2540, 1999.

    PubMed  CAS  Google Scholar 

  5. Fertil B, Malaise EP: Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11:1699–1707, 1985.

    PubMed  CAS  Google Scholar 

  6. Deschavanne PJ, Fertil B: A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 34:251–266, 1996.

    PubMed  CAS  Google Scholar 

  7. Lee J, Hodgson D, Chow E, et al.: A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 104:1894–1900, 2005.

    Article  PubMed  Google Scholar 

  8. Fossa SD, Kjolseth I, Lund G: Radiotherapy of metastases from renal cancer. Eur Urol 8:340–342, 1982.

    PubMed  CAS  Google Scholar 

  9. Halperin EC, Harisiadis L: The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51:614–617, 1983.

    Article  PubMed  CAS  Google Scholar 

  10. DiBiase SJ, Valicenti RK, Schultz D, et al.: Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 158:746–749, 1997.

    Article  PubMed  CAS  Google Scholar 

  11. Onufrey V, Mohiuddin M: Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 11:2007–2009, 1985.

    PubMed  CAS  Google Scholar 

  12. Seitz W, Karcher KH, Binder W: Radiotherapy of metastatic renal cell carcinoma. Sem Surg Oncol 4:100–102, 1988.

    CAS  Google Scholar 

  13. Bayley A, Milosevic M, Blend R, et al.: A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer 92:303–310, 2001.

    Article  PubMed  CAS  Google Scholar 

  14. Arcangeli G, Micheli A, Giannarelli D, et al.: The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol 14:95–101, 1989.

    Article  PubMed  CAS  Google Scholar 

  15. Jensen NH, Roesdahl K: Single-dose irradiation of bone metastases. Acta Radiol Ther Phys Biol 15:337–339, 1976.

    PubMed  CAS  Google Scholar 

  16. Schocker JD, Brady LW: Radiation therapy for bone metastasis. Clin Orthopaed Related Res 169:38–43, 1982.

    Google Scholar 

  17. Vargha ZO, Glicksman AS, Boland J: Single-dose radiation therapy in the palliation of metastatic disease. Radiology 93:1181–1184, 1969.

    PubMed  CAS  Google Scholar 

  18. Brinkmann OA, Bruns F, Prott FJ, et al.: Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC). Anticancer Res 19:1583–1587, 1999.

    PubMed  CAS  Google Scholar 

  19. Huguenin PU, Kieser S, Glanzmann C, et al.: Radiotherapy for metastatic carcinomas of the kidney or melanomas: an analysis using palliative end points. Int J Radiat Oncol Biol Phys 41:401–405, 1998.

    PubMed  CAS  Google Scholar 

  20. Redman BG, Hillman GG, Flaherty L, et al.: Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma. Clin Cancer Res 4:283–286, 1998.

    PubMed  CAS  Google Scholar 

  21. Price P, Hoskin PJ, Easton D, et al.: Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6:247–255, 1986.

    Article  PubMed  CAS  Google Scholar 

  22. Hoskin PJ, Price P, Easton D, et al.: A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 23:74–78, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Steenland E, Leer JW, van Houwelingen H, et al.: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. [see comment] [Erratum appears in Radiother Oncol 1999 Nov;53(2):167.] Radiother Oncol 52:101–109, 1999.

    Article  PubMed  CAS  Google Scholar 

  24. Niewald M, Tkocz HJ, Abel U, et al.: Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 36:1085–1089,1996.

    PubMed  CAS  Google Scholar 

  25. Nielsen OS, Bentzen SM, Sandberg E, et al.: Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47:233–240, 1998.

    Article  PubMed  CAS  Google Scholar 

  26. Jeremic B, Shibamoto Y, Acimovic L, et al.: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 42:161–167, 1998.

    PubMed  CAS  Google Scholar 

  27. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52:111–121, 1999.

    Google Scholar 

  28. Gaze MN, Kelly CG, Kerr GR, et al.: Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 45:109–116, 1997.

    Article  PubMed  CAS  Google Scholar 

  29. Duncan G, Duncan W, Maher EJ: Patterns of palliative radiotherapy in Canada. Clin Oncol (Royal College of Radiologists) 5:92–97, 1993.

    CAS  Google Scholar 

  30. Chow E, Danjoux C, Wong R, et al.: Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. [see comment] Radiother Oncol 56:305–314,2000.

    Article  PubMed  CAS  Google Scholar 

  31. Ben-Josef E, Shamsa F, Williams AO, et al.: Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 40:915–921, 1998.

    Article  PubMed  CAS  Google Scholar 

  32. Bentzen SM, Hoskin P, Roos D, et al.: Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or...? [comment] Int J Radiat Oncol Biol Phys 46:681–683, 2000.

    PubMed  CAS  Google Scholar 

  33. Salazar OM, Rubin P, Hendrickson FR, et al.: Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 58:29–36, 1986.

    CAS  Google Scholar 

  34. Kuban DA, Delbridge T, el-Mahdi AM, et al.: Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate. J Urol 141:572–574, 1989.\balance

    Google Scholar 

  35. Fitzpatrick PJ, Rider WD: Half body radiotherapy. Int J Radiat Oncol Biol Phys 1:197–207, 1976.

    PubMed  CAS  Google Scholar 

  36. Hoskin PJ, Ford HT, Harmer CL: Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients. Clin Oncol (Royal College of Radiologists) 1:67–69, 1989.

    CAS  Google Scholar 

  37. Quilty PM, Kirk D, Bolger JJ, et al.: A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 31:33–40, 1994.

    Article  PubMed  CAS  Google Scholar 

  38. Van Dyk J, Keane TJ, Kan S, et al.: Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung. Int J Radiat Oncol Biol Phys 7:461–467, 1981.

    PubMed  Google Scholar 

  39. Salazar OM, Sandhu T, da Motta NW, et al.: Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). [see comment] Int J Radiat Oncol Biol Phys 50:765–775, 2001.

    PubMed  CAS  Google Scholar 

  40. Zelefsky MJ, Scher HI, Forman JD, et al.: Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens. Int J Radiat Oncol Biol Phys 17:1281–1285, 1989.

    PubMed  CAS  Google Scholar 

  41. Bauman G, Charette M, Reid R, et al.: Radiopharmaceuticals for the palliation of painful bone metastasis—-a systemic review. Radiother Oncol 75:258–270, 2005.

    PubMed  CAS  Google Scholar 

  42. Finlay IG, Mason MD, Shelley M: Radioisotopes for the palliation of metastatic bone cancer: a systematic review. [see comment]. Lancet Oncol 6:392–400, 2005.

    Article  PubMed  CAS  Google Scholar 

  43. Wersall PJ, Blomgren H, Lax I, et al.: Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 77:88–95, 2005.

    Article  PubMed  Google Scholar 

  44. Loizzi M, Sollitto F, Sardelli P, et al.: Endothoracic nodules in patients who under-went nephrectomy for renal cell carcinoma. Results of surgical resection. Minerva Med 94:103–110, 2003.

    CAS  Google Scholar 

  45. Kavolius JP, Mastorakos DP, Pavlovich C, et al.: Resection of metastatic renal cell carcinoma. J Clin Oncol 16:2261–2266, 1998.

    PubMed  CAS  Google Scholar 

  46. Pohlman B, Sweetenham J, Macklis RM: Review of clinical radioimmunotherapy. Expert Rev Anticancer Ther 6:445–461, 2006.

    Article  PubMed  CAS  Google Scholar 

  47. Ling CC, Yorke E, Fuks Z: From IMRT to IGRT: frontierland or neverland? Radiother Oncol 78:119–122, 2006.

    Article  PubMed  Google Scholar 

  48. Fuks Z, Kolesnick R: Engaging the vascular component of the tumor response. Cancer Cell 8:89–91, 2005.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Warde, P.R., Gospodarowicz, M.K. (2008). Radiotherapy. In: Rosette, J.J.d., Sternberg, C.N., Poppel, H.P.v. (eds) Renal Cell Cancer. Springer, London. https://doi.org/10.1007/978-1-84628-763-3_43

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-763-3_43

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-385-7

  • Online ISBN: 978-1-84628-763-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics